Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Journal of Cancer (Oxford, England : 1990)|May 13, 2011
Critical review of economic evaluations in multiple myeloma: an overview of the economic evidence and quality of the methodologyJennifer G Gaultney, W K Redekop, Pieter Sonneveld, et al.
Expert Review of Anticancer Therapy|June 22, 2012
Novel anticancer agents for multiple myeloma: a review of the evidence for their therapeutic and economic valueJennifer G Gaultney, William K Redekop, Pieter Sonneveld, et al.
Pharmacogenomics|April 1, 2011
Application of cost-effectiveness analysis to demonstrate the potential value of companion diagnostics in chronic myeloid leukemiaJennifer G Gaultney, Enrique Sanhueza, Jeroen J Janssen, et al.
Frontiers in Pharmacology|July 17, 2025
Value attribution for oncology combination regimens: going beyond frameworks to balance innovation, access, and affordabilityJennifer G Gaultney, Daniel Ollendorf, Medha Sasane, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2022
Comparison of Alternative Methods to Assess the Cost-Effectiveness of Tumor-Agnostic Therapies: A Triangulation Approach Using Larotrectinib as a Case StudyAndrew Briggs, Beth Wehler, Jennifer G Gaultney, et al.
Pharmacogenomics|January 16, 2018
Potential therapeutic and economic value of risk-stratified treatment as initial treatment of multiple myeloma in EuropeJennifer G Gaultney, Therese W Ng, Carin A Uyl-de Groot, et al.
Applied Health Economics and Health Policy|May 24, 2021
Developing a Framework for the Health Technology Assessment of Histology-independent Precision Oncology TherapiesJennifer G Gaultney, Jacoline C Bouvy, Richard H Chapman, et al.
Health Policy (Amsterdam, Netherlands)|December 6, 2014
Experience with outcomes research into the real-world effectiveness of novel therapies in Dutch daily practice from the context of conditional reimbursementJennifer G Gaultney, Margreet G Franken, Carin A Uyl-de Groot, et al.
Applied Health Economics and Health Policy|January 6, 2018
Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate CancerMichel L Peters, Claudine de Meijer, Dirk Wyndaele, et al.
Applied Health Economics and Health Policy|September 4, 2017
Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate CancerMichel L Peters, Claudine de Meijer, Dirk Wyndaele, et al.
Pageof 2